Key facts
- It has raised $1.1B; the latest was Debt - General ($30.0M) in Jul 2024.
- Notable investors include Plug and Play Tech Center, General Catalyst, Insight Partners (New York), Gaingels, BoxGroup — 50 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 50 names
- ·Watchlist + deal alerts for Ro
- ·The full record, as it builds
Funding rounds
No funding rounds for Ro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ro
Operator of a direct-to-consumer telehealth platform intended to handle everything from diagnosis to convenient medication delivery. The company's platform allows people to get in touch with physicians and has end-to-end services, some for erectile dysfunction and others to help people quit smoking, enabling users to get access to free medication delivery and personalized treatment.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 831
- Website
- ro.co/
- Ownership
- Privately Held (backing)
Ro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ro in its N-PORT filings yet. We sweep new filings monthly.